Evidence map›Paper›PMID 41383851›Full record

ArticleFrontiers in cellular and infection microbiology2025

Silver multilayer coating on orthopedic implant material of different alloys and surfaces significantly reduces bacterial colonization.

Lydia T D Speijker, Janine Fechter, Rainer Bargon, Jozef Dingemans, Jacobus J Arts, Paul H M Savelkoul, Inge H M van Loo

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Biofilm Formation Patterns ofAntibiotics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lydia T D SpeijkerDepartment of Medical Microbiology, Infectious Disease and Infection Prevention, Maastricht University Medical Centre, Maastricht, Netherlands.
Janine FechterDepartment of Research and Development, Aesculap AG, Tuttlingen, Germany.
Rainer BargonDepartment of Research and Development, Aesculap AG, Tuttlingen, Germany.
Jozef DingemansClinical Laboratory of Molecular Microbiology, Jessa Hospital, Hasselt, Belgium.
Jacobus J ArtsCare and Public Health Research Institute (CAPRHI), Maastricht University, Maastricht, Netherlands.
Paul H M SavelkoulDepartment of Medical Microbiology, Infectious Disease and Infection Prevention, Maastricht University Medical Centre, Maastricht, Netherlands.
Inge H M van LooDepartment of Medical Microbiology, Infectious Disease and Infection Prevention, Maastricht University Medical Centre, Maastricht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Prosthetic joint infections (PJI) affect 1-3% of prosthetic joint replacements, frequently linked to biofilm formation on implant surfaces. PJIs account for 13.0-31.3% of all revision surgeries. As treatment is not always successful, prevention remains critical. Currently, silver based antimicrobial coatings are justified in select high-risk arthroplasty cases, restricted to metal surfaces. An antibacterial silver multilayer coating (SML) has been developed for implant materials: titanium alloy (Ti) and cobalt-chromium-molybdenum alloy (CoCr), often used in hip or knee prostheses. The SML coating is intended for revision implants, which are often required due to infection related implant failure. This study investigates the antibacterial performance of the SML coating across different surfaces and implant materials, using multiple bacterial strains not previously investigated to this extent. Methods: Antibacterial efficacy of the SML coating was assessed by quantifying colony forming units (CFU) reduction on Ti6Al4V and Co28Cr6M discs with three different surfaces (polished and two grades of corundum blasted (CB)). Results: Across all materials and strains, the SML coating achieved >99.2% and >0.9-4.0 CFU log Discussion and conclusion: These findings demonstrate a thorough and broad-spectrum antibacterial activity of the SML coating across diverse implant materials and surface textures. Future studies will focus on testing clinical PJI isolates in both

Indexed as

AlloysAnti-Bacterial AgentsBacteriaCoated Materials, BiocompatibleProstheses and ImplantsSilverBiofilmsHumansMicrobial Sensitivity TestsProsthesis-Related InfectionsPseudomonas aeruginosaStaphylococcus aureusStaphylococcus epidermidisSurface PropertiesTitaniumAlloysAnti-Bacterial AgentsCoated Materials, BiocompatibleSilverTitaniumtitanium alloy (TiAl6V4)antibacterial agentsin vitromaterialsprevention of bacterial colonizationprosthetic joint infectionsilver

Identifiers

PMID41383851
PMCPMC12689873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.